Clear Search

Showing 1 result for “Martinez-Osuna P”.

August 2020

Eficacia y Seguridad a Largo Plazo de Baricitinib con y sin Metotrexato para el Tratamiento de la Artritis Reumatoide: Experiencia con la Continuación de Baricitinib Monoterapia o Después del Cambio de Metotrexato Monoterapia o Baricitinib más Metotrexato

Arthritis Care Res (Hoboken) 2020;72(8):1112-1121

This 24-week update from the baricitinib RA-BEYOND LTE study follows patients previously treated in the pivotal study RA-BEGIN. It demonstrates the maintained safety and efficacy of baricitinib monotherapy, and the effects of concurrent MTX treatment on response rates and patient reported outcomes. Previous P3 study RA-BEGIN demonstrated the superior efficacy of 4mg baricitinib compared to MTX monotherapy up to 52 weeks, with no major safety events being identified. At the end of the trial, pati...

mas…